Why the study?
What are the clinical features, risk factors, and management strategies for neuroleptic malignant syndrome?
Population
Patients treated with neuroleptic drugs or dopamine antagonists
Design
Review
Authors
Loading...
Demands sustained vigilance for NMS with neuroleptic use; leaves open refinement of risk prediction and prevention strategies.
What are the clinical features, risk factors, and management strategies for neuroleptic malignant syndrome?
NMS is a rare but potentially lethal complication of neuroleptic therapy that requires prompt recognition and management.
Kohen et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: